Skip to content
Trial Eligibility
Menu

The Rise in Robotic Atypical Segmentectomies

NCT04644952

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Lung Carcinoma

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
Any age
Sex
All
Healthy volunteers
Not accepted
Sponsor
M.D. Anderson Cancer Center
Last updated on ClinicalTrials.gov
September 14, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • M D Anderson Cancer Center · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.